SCHEMBL25937157

SCHEMBL25937157

CC1(C)c2ccccc2-c2cc3c(cc21)-c1ccccc1C3(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 2/20 0.52
KDM4E B2RXH2 1/20 0.52
OPRK1 P41145 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
POLB P06746 1/20 0.37
PGR P06401 3/20 0.36
MLNR O43193 1/20 0.35
NR1I2 O75469 1/20 0.35
CHRM2 P08172 1/20 0.35
ADRB1 P08588 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD2 P14416 1/20 0.35
ADRA2B P18089 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23637493 0.87 MEN1 (0.42) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL18864169 0.87 MEN1 (0.50) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL5062909 0.84 HTR2A (0.43) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL5014621 0.84 HTR2A (0.43) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL16996089 0.84 MEN1 (0.40) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL16596683 0.84 PDK2 (0.46) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL29440301 0.84 PDK2 (0.46) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL16996088 0.84 MEN1 (0.40) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL29874813 0.84 PDK2 (0.46) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL17854342 0.84 MEN1 (0.41) LMNAMEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230272274-A1 FORMULATIONS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-08-31 US disclosed
US-20230250112-A1 ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-08-10 US disclosed
US-20230255112-A1 ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD ZHEJIANG BRILLIANT OPTOELECTRONIC TECHNOLOGY CO., LTD. (CN) 2023-08-10 US disclosed
US-11672174-B2 Pyrene-triazine derivative and applications thereof in organic electronic component GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250112-A1 ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD AOX1, AOC2, OR10J3 LMNA 2910/4885MEN1 1783/4885KMT2A 4013/4885
US-20230255112-A1 ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD OR10J3, AOX1, AOC3 LMNA 3057/4885MEN1 2868/4885KMT2A 4629/4885
US-11672174-B2 Pyrene-triazine derivative and applications thereof in organic electronic component TPR, TRPC5, TRPC4 LMNA 1829/4885MEN1 4828/4885KMT2A 4435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.